These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3530627)

  • 1. Susceptibility of Candida albicans to flucytosine when tested in different formulations of yeast nitrogen base broth.
    Galgiani JN; Yturralde CA; Dugger KO
    Diagn Microbiol Infect Dis; 1986 Sep; 5(3):273-6. PubMed ID: 3530627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media.
    Calhoun DL; Galgiani JN
    Antimicrob Agents Chemother; 1984 Sep; 26(3):364-7. PubMed ID: 6391370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of buffers on testing of Candida species susceptibility to flucytosine.
    MacKerrow SD; Merry JM; Hoeprich PD
    J Clin Microbiol; 1987 May; 25(5):885-8. PubMed ID: 3294891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
    Rodriguez-Tudela JL; Martinez-Suárez JV
    J Antimicrob Chemother; 1995 Jun; 35(6):739-49. PubMed ID: 7559186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three methods for in vitro susceptibility testing of Candida species with flucytosine.
    Moore CB; Walls CM; Denning DW
    J Antimicrob Chemother; 2003 Feb; 51(2):297-304. PubMed ID: 12562694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
    Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
    Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The susceptibility of Candida albicans strains to selected anticancer drugs and flucytosine, relevance of the presence of self-splicing intron in 25S rDNA.
    Król J; Nawrot U; Bartoszewicz M
    J Mycol Med; 2019 Apr; 29(1):39-43. PubMed ID: 30545669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicans.
    Shadomy S; Shadomy HJ
    Diagn Microbiol Infect Dis; 1991; 14(1):21-2. PubMed ID: 2013207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD; Huston AC
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
    Brouwer N; Kohen J; Jamie J; Vemulpad S
    J Microbiol Methods; 2006 Aug; 66(2):234-41. PubMed ID: 16406566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 5-fluorocytosine on the temperature profile of Candida albicans.
    Lemos-Carolino M; Madeira-Lopes A
    Sabouraudia; 1984; 22(4):351-4. PubMed ID: 6390737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of isothermal microcalorimetry to quantify the influence of glucose and antifungals on the growth of Candida albicans in urine.
    Wernli L; Bonkat G; Gasser TC; Bachmann A; Braissant O
    J Appl Microbiol; 2013 Nov; 115(5):1186-93. PubMed ID: 23865534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disk diffusion method for fluconazole susceptibility testing of Candida albicans strains.
    Yücesoy M; Guldaş NS; Yuluğ N
    J Chemother; 2001 Apr; 13(2):161-6. PubMed ID: 11330363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorocytosine and Candida yeasts.
    Fabbri A; Tacchella A; Belli ML; Toriello E
    Chemioterapia; 1987 Feb; 6(1):8-11. PubMed ID: 3549011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.